Sector ratings Iqvia Holdings Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 14:49:12 14/01/2026 GMT			5-day change	1st Jan Change
241.57 ^USD	0.00%		-1.28%	+6.99%

01-13	Rothschild & Co Redburn Adjusts IQVIA Price Target to $287 From $254, Maintains Buy Rating	MT
01-12	Alembic Pharmaceuticals Limited Receives USFDA Tentative Approval for Bosutinib Tablets, 400 Mg	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
IQVIA HOLDINGS INC.	41.14B		AAA
LONZA GROUP AG	49.13B		AAA
BEONE MEDICINES AG	38.85B		-
CELLTRION, INC.	32.74B		A
REVOLUTION MEDICINES, INC.	23.19B	-	B	-		-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	16.09B	-	-	-	-	-	-	-
MEDPACE HOLDINGS, INC.	17.14B		BBB
EUROFINS SCIENTIFIC SE	15.04B		AA
ICON PUBLIC LIMITED COMPANY	14B		AA
IONIS PHARMACEUTICALS, INC.	12.87B	-	A	-		-
ASCENDIS PHARMA A/S	13.2B	-	-	-		-
TEMPUS AI, INC.	11.95B	-	A	-		-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.78B		A
BIO-TECHNE CORPORATION	10.34B		A
QIAGEN N.V.	9.72B		AAA
ABIVAX	9.42B	-	BBB	-		-
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
PRAXIS PRECISION MEDICINES, INC.	7.7B	-	B	-		-
PHARMARON BEIJING CO., LTD.	7.86B		AA
HANGZHOU TIGERMED CONSULTING CO., LTD	7.44B		AAA
Average	17.85B		AA
Weighted average by Cap.			AA